Dupilumab shows promise in eosinophilic gastritis

Nature Reviews Gastroenterology and Hepatology · Published 2026-07-17 · DOI 10.1038/s41575-026-01239-z

Authors (1)

Eleni Kotsiliti

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kotsiliti, E. (2026). Dupilumab shows promise in eosinophilic gastritis. Nature Reviews Gastroenterology and Hepatology. https://doi.org/10.1038/s41575-026-01239-z

Related articles

• Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• Microplastics, nanoplastics and liver disease: an emerging health concern? · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• Global position statement supporting a World Health Assembly resolution on steatotic liver disease · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• Precision nutrition for the prevention and management of inflammatory bowel disease · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• Physical activity and the gut · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• Gut microbiota induce browning of white adipose tissue · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• Mechanisms and clinical outcomes linking HLA-DRB1*01:03 and IBD · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• Positive results for daraxonrasib for previously treated metastatic pancreatic cancer · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
• European Congress on Obesity 2026 · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal